食品与发酵工业 >

2021 , Vol. 47 >Issue 1: 125 - 131

DOI: https://doi.org/10.13995/j.cnki.11-1802/ts.024501

研究报告

嗜酸乳杆菌La28对丙戊酸暴露引起的子代大鼠外周炎症和肝损伤的缓解作用

  • 孔庆敏 ,
  • 朱慧越 ,
  • 田培郡 ,
  • 赵建新 ,
  • 张灏 ,
  • 陈卫 ,
  • 王刚
展开
  • (江南大学 食品学院,江苏 无锡,214122)
博士研究生(王刚副教授为通讯作者,E-mail:wanggang@jiangnan.edu.cn)

收稿日期: 2020-05-20

  修回日期: 2020-07-15

  网络出版日期: 2021-02-03

基金资助

国家自然科学基金项目(31972052);中央高校基本科研业务费专项资金项目(JUSRP22006)

收起

Alleviation effects on peripheral inflammation and liver damage by Lactobacillus acidophilus La28 in offspring rats induced by valproic acid exposure

  • KONG Qingmin ,
  • ZHU Huiyue ,
  • TIAN Peijun ,
  • ZHAO Jianxin ,
  • ZHANG Hao ,
  • CHEN Wei ,
  • WANG Gang
Expand
  • (School of Food Science and Technology, Jiangnan University, Wuxi 214122, China)

Received date: 2020-05-20

  Revised date: 2020-07-15

  Online published: 2021-02-03

Fold

摘要

为评价嗜酸乳杆菌La28对丙戊酸(valproic acid,VPA)暴露引起的子代大鼠外周炎症和肝损伤的作用,同时明确其对VPA大鼠肠道菌群的调节作用。在大鼠孕期12.5 d腹腔注射VPA和生理盐水,断奶后,随机选取雄性子代分成对照组、VPA组、La28组和利培酮(MED)组(n=5),La28组每天灌胃菌液(109 CFU/mL),对照、VPA和MED组灌胃等量生理盐水和药物,干预期28 d。干预结束后,评价外周炎症、肝功能和肠道菌群的改善情况。与VPA组大鼠相比,嗜酸乳杆菌La28干预能显著地改善VPA大鼠的外周炎症和肝功能,其中对IL-6、TNF-α、ALT和GGT的作用效果更为显著。此外,嗜酸乳杆菌La28可能通过上调Allobaculumhe和Mucispirillum的相对丰度,增加厚壁菌门丰度,降低拟杆菌门丰度从而改善VPA暴露引起子代大鼠的神经炎症和肝功能。

关键词： 嗜酸乳杆菌La28; 丙戊酸; 外周炎症; 肝功能; 肠道菌群

本文引用格式

孔庆敏 , 朱慧越 , 田培郡 , 赵建新 , 张灏 , 陈卫 , 王刚 . 嗜酸乳杆菌La28对丙戊酸暴露引起的子代大鼠外周炎症和肝损伤的缓解作用[J]. 食品与发酵工业, 2021 , 47(1) : 125 -131 . DOI: 10.13995/j.cnki.11-1802/ts.024501

Abstract

To evaluate the effects of Lactobacillus acidophilus La28 on relieving peripheral inflammation and improving liver function in rats induced by valproic acid, Wistar rats were intraperitoneally injected with VPA or normal saline on day 12.5 after pregnancy and the male offspring were randomly grouped as the control group, VPA group, La28 group and risperidone (MED) group (n=5). La28 group was treated with L. acidophilus La28 (109 CFU/mL) by gavage for 28 days. The control, VPA and MED groups were treated with equivalent saline and risperidone by gavage. After the intervention, peripheral inflammation, liver function and gut microbiota were evaluated. Compared with rats in VPA group, L. acidophilus La28 significantly improved peripheral inflammation and liver function in rats. The effects on IL-6, TNF-α, alanine aminotransferase (ALT) andγ-glutamyl transpeptidase (GGT) were more significant. In addition, L. acidophilus La28 might improve the peripheral inflammation and liver function through regulating the relative abundance of Allobaculumhe and Mucispirillum, increasing Firmicutes abundance, and decreasing Bacteroides abundance.

Key words： Lactobacillus acidophilus La28; valproic acid; peripheral inflammation; liver function; gut microbiota

参考文献

[1] VAJDA F J E,O’BRIEN T J,GRAHAM J E,et al.Valproate-associated foetal malformations-rates of occurrence,risks in attempted avoidance[J].Acta Neurologica Scandinavica,2018,139 (1):42-48.
[2] ABDELKADER N F,ELYAMANY M,GAD A M,et al.Ellagic acid attenuates liver toxicity induced by valproic acid in rats[J].Journal of Pharmacological Sciences, 2020,143(1):23-29.
[3] BASSETT J T,RODRIGUEZ B,MULLIGAN L,et al.Acute liver failure in a military recruit treated with valproic acid and harboring a previously unrecognized polg-1 mutation[J].Epilepsy & behavior reports,2019,12:100 342.
[4] ZHAO G,GAO J Q,LIANG S,et al.Study of the serum levels of polyunsaturated fatty acids and the expression of related liver metabolic enzymes in a rat valproate-induced autism model[J].International Journal of Developmental Neuroscience,2015,44:14-21.
[5] RODIER P M,INGRAM J L,TISDALE B,et al.Embryological origin for autism:Developmental anomalies of the cranial nerve motor nuclei[J].the Journal of Comparative Neurology,1996,370(2):247-261.
[6] HOLINGUE C,NEWILL C,LEE L,et al.Gastrointestinal symptoms in autism spectrum disorder:A review of the literature on ascertainment and prevalence[J].Autism Research,2018,11(1):24-36.
[7] BRANISTE V,ALASMAKH M,KOWAL C,et al.The gut microbiota influences blood-brain barrier permeability in mice[J].Science Translational Medicine,2014,6(263).DOI:10.1126/scitranslmed.3 009 759.
[8] TRIPATHI A,DEBELIUS J W,BRENNER D A,et al.Publisher correction:The gut-liver axis and the intersection with the microbiome[J].Nature Reviews Gastroenterology & Hepatology,2018,15(7):785-785.
[9] TANOSHIMA M,KOBAYASHI T,TANOSHIMA R,et al.Risks of congenital malformations in offspring exposed to valproic acid in utero:A systematic review and cumulative meta-analysis[J].Clinical Pharmacology & Therapeutics,2015,98(4):417-441.
[10] YAN S,YANG B,ZHAO J C,et al.A ropy exopolysaccharide producing strain Bifidobacterium longum subsp.longum YS108R alleviates DSS-induced colitis by maintenance of the mucosal barrier and gut microbiota modulation[J].Food & Function,2019,10(3):1 595-1 608.
[11] FOLEY A G,GANNON S,ROMBACH-MULLAN N,et al.Class ihistone deacetylase inhibition ameliorates social cognition and cell adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder[J].Neuropharmacology,2012,63(4):750-760.
[12] SCHNEIDER T,ROMAN A,AGNIESZKA B K,et al.Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid[J].Psychoneuroendocrinology,2008,33(6):728-740.
[13] DOENYAS C.Gut microbiota,inflammation,and probiotics on neural development in autism spectrum disorder[J].Neuroscience,2018,374:271-286.
[14] FERNANDES BS,STEINER J,BERNSTEIN H G,et al.C-reactive protein is increased in schizophrenia but is not altered by antipsychotics:Meta-analysis and implications[J].Molecular Psychiatry,2016,21(4):554-564.
[15] KEMGANG T S,KAPILA S,SHANMUGAM V P,et al.Cross-talk between probiotic lactobacilli and host immune system[J].Journal of Applied Microbiology,2014,117(2):303-319.
[16] RAISON C L,PIKALOV A,SIU C,et al.C-reactive protein and response to lurasidone in patients with bipolar depression[J].Brain Behavior and Immunity,2018,73:717-724.
[17] FELGER J C,HAROON E,PATEL T A,et al.What does plasma crp tell us about peripheral and central inflammation in depression?[J].Molecular Psychiatry,2020,25(6):1 301-1 311.
[18] CURRAIS A,FARROKHI C,DARGUSCH R,et al.Dietary glycemic index modulates the behavioral and biochemical abnormalities associated with autism spectrum disorder[J].Molecular Psychiatry,2016,21(3):426-436.
[19] GUPTA S,SAMRA D,AGRAWAL S.Adaptive and innate immune responses in autism:Rationale for therapeutic use of intravenous immunoglobulin[J].Journal of Clinical Immunology,2010,30:S90-S96.
[20] MILOSEVIC I,VUJOVIC A,BARAC A,et al.Gut-liver axis,gut microbiota,and its modulation in the management of liver diseases:A review of the literature[J].International Journal of Molecular Sciences,2019,20(2).DOI:10.3390/ijms20020395.
[21] BAJAJ J S.Alcohol,liver disease and the gut microbiota[J].Nature Reviews Gastroenterology & Hepatology,2019,16(4):235-246.
[22] CHAIDEZ V,HANSEN R L,HERTZ-PICCIOTTO I.Gastrointestinal problems in children with autism,developmental delays or typical development[J].Journal of Autism and Developmental Disorders,2014,44(5):1 117-1 127.
[23] LIU F T,LI J,WU F,et al.Altered composition and function of intestinal microbiota in autism spectrum disorders:A systematic review[J].Translational psychiatry,2019,9(1):43.
[24] SHAABAN S Y,EL G Y G,MEHANNA N S,et al.The role of probiotics in children with autism spectrum disorder:A prospective,open-label study[J].Nutritional Neuroscience,2018,21(9):676-681.
[25] ZHANG H,YE H C,JIN Z,ET AL.Prospective study of probiotic supplementation results in immune stimulation and improvement of upper respiratory infection rate[J].Synthetic and Systems Biotechnology,2018,3(2):113-120.
[26] SAPUTRO I D,PUTRA O N,PEBRIANTON H,et al.Effects of probiotic administration on IGA and IL-6 level in severe burn patients:A randomized trial[J].Annals of Burns and Fire Disasters,2019,32(1):70-76.
[27] MANCINI A,CAMPAGNA F,AMODIO P,et al.Gut:liver:brain axis:The microbial challenge in the hepatic encephalopathy[J].Food & Function,2018,9(3):1 373-1 388.
[28] YE J,LV L,WU W,et al.Butyrate protects mice against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function,attenuating inflammation and reducing endotoxin levels[J].Frontiers In microbiology,2018,9(21).DOI:10.3389/fmicb.2018.01967.
[29] MILOSEVIC I,VUJOVIC A,BARAC A,et al.Gut-Liver axis,gut microbiota,and its modulation in the management of liver diseases:A review of the literature[J].International Journal of Molecular Sciences,2019,20(2):395-399.
[30] ALCOHOL B J.Liver disease and the gut microbiota[J].Nature Reviews Gastroenterology & Hepatology,2019,16(4):235-246.
[31] CHAIDEZ V,HANSEN R L,HERTZ-PICCIOTTO I.Gastrointestinal problems in children with autism,developmental delays or typical development[J].Journal of Autism and Developmental Disorders,2014,44(5):1 117-1 127.
[32] LIU F,LI J,WU F,et al.Altered composition and function of intestinal microbiota in autism spectrum disorders:A systematic review[J].Translational Psychiatry,2019,9(1):43.
[33] SHAABAN S Y,GENDY Y G,MEHANNA N S,et al.The role of probiotics in children with autism spectrum disorder:A prospective,open-label study[J].Nutritional Neuroscience,2017,21(9):676-681.
Options
文章导航

/

〈 〉

技术支持：北京玛格泰克科技发展有限公司